Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design

Abstract

Background: Despite developments in surgical techniques and medical care, people with a Fontan circulation still experience long-term complications; non-invasive therapies to optimize the circulation have not been established. Exercise intolerance affects the majority of the population and is associated with worse prognosis. Historically, people living with a Fontan circulation were advised to avoid physical activity, but a small number of heterogenous, predominantly uncontrolled studies have shown that exercise training is safe-and for unique reasons, may even be of heightened importance in the setting of Fontan physiology. The mechanisms underlying improvements in aerobic exercise capacity and the effects of exercise training on circulatory and end-organ function remain incompletely understood. Furthermore, the optimal methods of exercise prescription are poorly characterized. This highlights the need for large, well-designed, multi-center, randomized, controlled trials. Aims and Methods: The Fontan Fitness Intervention Trial (F-FIT)-a phase III clinical trial-aims to optimize exercise prescription and delivery in people with a Fontan circulation. In this multi-center, randomized, controlled study, eligible Fontan participants will be randomized to either a 4-month supervised aerobic and resistance exercise training program of moderate-to-vigorous intensity followed by an 8-month maintenance phase; or usual care (control group). Adolescent and adult (≥16 years) Fontan participants will be randomized to either traditional face-to-face exercise training, telehealth exercise training, or usual care in a three-arm trial with an allocation of 2:2:1 (traditional:telehealth:control). Children (<16 years) will be randomized to either a physical activity and exercise program of moderate-to-vigorous intensity or usual care in a two-arm trial with a 1:1 allocation. The primary outcome is a change in aerobic exercise capacity (peak oxygen uptake) at 4-months. Secondary outcomes include safety, and changes in cardiopulmonary exercise testing measures, peripheral venous pressure, respiratory muscle and lung function, body composition, liver stiffness, neuropsychological and neurocognitive function, physical activity levels, dietary and nutritional status, vascular function, neurohormonal activation, metabolites, cardiac function, quality of life, musculoskeletal fitness, and health care utilization. Outcome measures will be assessed at baseline, 4-months, and 12-months. This manuscript will describe the pathophysiology of exercise intolerance in the Fontan circulation and the rationale and protocol for the F-FIT. (Copyright © 2022 Tran, Gibson, Maiorana, Verrall, Baker, Clode, Lubans, Zannino, Bullock, Ferrie, Briody, Simm, Wijesekera, D'Almeida, Gosbell, Davis, Weintraub, Keech, Puranik, Ugander, Justo, Zentner, Majumdar, Grigg, Coombes, d'Udekem, Morris, Ayer, Celermajer and Cordina.)eCollection. Cited Medium: Print. NLM ISO Abbr: Front Pediatr. PubMed Central ID: PMC8771702. Linked References: Circ Heart Fail. 2012 Sep 1;5(5):579-85. (PMID: 22773109); Cardiol Young. 2021 May;31(5):792-798. (PMID: 33455600); J Cardiopulm Rehabil Prev. 2020 Jan;40(1):E1-E4. (PMID: 31868841); Int J Pediatr. 2010;2010:. (PMID: 20871839); J Am Coll Cardiol. 2006 Jun 20;47(12):2528-35. (PMID: 16781384); Int J Behav Nutr Phys Act. 2017 Feb 23;14(1):24. (PMID: 28231794); Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1779-H1788. (PMID: 30239235); Eur Respir Rev. 2016 Dec;25(142):438-450. (PMID: 27903666); Heart. 2011 Jul;97(14):1164-8. (PMID: 21258001); J Am Coll Cardiol. 2019 Apr 2;73(12):e81-e192. (PMID: 30121239); J Am Coll Cardiol. 2001 Jun 1;37(7):1967-74. (PMID: 11401140); Cardiol Young. 2000 Mar;10(2):107-14. (PMID: 10817293); Heart. 2020 Feb;106(3):233-239. (PMID: 31492699); Cardiol Young. 2020 May;30(5):674-680. (PMID: 32299527); Int J Cardiol. 2018 Dec 1;272:77-83. (PMID: 30017529); Int J Cardiol. 2006 Feb 8;107(1):85-94. (PMID: 16046016); Semin Thorac Cardiovasc Surg. 2018 Winter;30(4):462-469. (PMID: 30063966); Circ Cardiovasc Imaging. 2018 Jul;11(7):e006738. (PMID: 29970379); J Am Heart Assoc. 2020 Apr 21;9(8):e015639. (PMID: 32290749); Circulation. 2005 Aug 9;112(6):828-35. (PMID: 16061735); Eur Heart J. 2005 Jul;26(14):1422-45. (PMID: 15923204); Congenit Heart Dis. 2009 Jan-Feb;4(1):2-11. (PMID: 19207396); Eur J Prev Cardiol. 2020 May;27(8):811-819. (PMID: 31744334); Congenit Heart Dis. 2008 Jul-Aug;3(4):254-61. (PMID: 18715459); Circulation. 2008 Mar 4;117(9):1228-37. (PMID: 18316499); Int J Cardiol. 2021 May 1;330:50-58. (PMID: 33571562); Intern Med J. 2014 Feb;44(2):148-55. (PMID: 24393144); J Am Heart Assoc. 2017 Aug 21;6(8):. (PMID: 28862962); Eur Heart J. 2013 Dec;34(47):3669-74. (PMID: 24204010); Int J Cardiol. 2019 Jan 1;274:80-87. (PMID: 30029798); Circulation. 1996 Oct 1;94(7):1642-6. (PMID: 8840856); Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. (PMID: 22336677); Cardiol Young. 2018 May;28(5):732-733. (PMID: 29486809); Circulation. 2020 Feb 25;141(8):641-651. (PMID: 31736357); Can J Cardiol. 2020 Sep;36(9):1499-1507. (PMID: 32284163); Prog Cardiovasc Dis. 2020 May - Jun;63(3):350-366. (PMID: 32201288); Congenit Heart Dis. 2017 Dec;12(6):699-710. (PMID: 28795517); Int J Cardiol. 2020 May 1;306:67-72. (PMID: 31785955); BMC Med Inform Decis Mak. 2016 Jul 19;16:95. (PMID: 27431419); Am J Physiol Heart Circ Physiol. 2014 Jul 1;307(1):H110-7. (PMID: 24791784); Int J Cardiol. 2010 Jan 21;138(2):196-205. (PMID: 19217676); Interact Cardiovasc Thorac Surg. 2010 Mar;10(3):428-33. (PMID: 19995891); Heart. 2019 Nov;105(21):1670-1679. (PMID: 31273028); Ann Thorac Surg. 2008 Mar;85(3):818-21. (PMID: 18291148); Cardiol Young. 2020 Aug;30(8):1138-1143. (PMID: 32571442); Circ Heart Fail. 2015 Mar;8(2):304-11. (PMID: 25550441); Am Heart J. 2007 Feb;153(2):201-11. (PMID: 17239677); Congenit Heart Dis. 2015 Mar-Apr;10(2):105-16. (PMID: 25196547); Congenit Heart Dis. 2019 Mar;14(2):147-155. (PMID: 30378270); Can J Cardiol. 2018 Oct;34(10 Suppl 2):S270-S277. (PMID: 30274637); Curr Opin Cardiol. 2019 Jan;34(1):79-86. (PMID: 30444760); Congenit Heart Dis. 2011 Jul-Aug;6(4):294-303. (PMID: 21418537); Int J Cardiol. 2017 May 15;235:6-10. (PMID: 28284501); Int J Cardiol. 2021 Oct 15;341:31-38. (PMID: 34375703); Ann Thorac Surg. 2021 Oct;112(4):1045-1054. (PMID: 33285131); J Am Coll Cardiol. 2008 Jul 8;52(2):108-13. (PMID: 18598888); Circulation. 2013 Feb 26;127(8):882-90. (PMID: 23382015); Heart. 2016 Jul 15;102(14):1081-6. (PMID: 27220691); Eur Heart J. 2021 Jan 1;42(1):17-96. (PMID: 32860412); Int J Cardiol. 2018 May 15;259:71-75. (PMID: 29472024); J Thorac Cardiovasc Surg. 2018 Mar;155(3):1192-1194. (PMID: 29157925); Heart. 2000 Jun;83(6):685-7. (PMID: 10814630); J Am Coll Cardiol. 2020 Dec 8;76(23):2755-2763. (PMID: 33272370); Heart. 2001 Mar;85(3):295-9. (PMID: 11179270); J Am Coll Cardiol. 2018 Mar 6;71(9):1009-1017. (PMID: 29495980); Circulation. 2020 Jul 28;142(4):e38-e39. (PMID: 32718251); Int J Cardiol. 2019 Dec 1;296:57-62. (PMID: 31230936); Heart Lung Circ. 2020 Jan;29(1):5-39. (PMID: 31735685); Circulation. 2014 Sep 9;130(11 Suppl 1):S32-8. (PMID: 25200053); J Am Heart Assoc. 2016 Sep 24;5(9):. (PMID: 27664807); Acta Paediatr. 2020 Apr;109(4):651-658. (PMID: 31737940); Am J Cardiol. 2004 Mar 15;93(6):792-7. (PMID: 15019898); Am J Cardiol. 2010 Apr 15;105(8):1169-75. (PMID: 20381672); J Am Coll Cardiol. 1990 May;15(6):1424-32. (PMID: 2329245); Circulation. 2011 Mar 22;123(11):1185-93. (PMID: 21382896); Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S93-S101. (PMID: 28375677); Eur J Prev Cardiol. 2015 Dec;22(12):1523-30. (PMID: 25038081); J Am Coll Cardiol. 2017 Jun 6;69(22):2735-2744. (PMID: 28571639); Interact Cardiovasc Thorac Surg. 2019 Feb 1;28(2):301-305. (PMID: 30085097); Sports Med. 2021 Apr;51(4):707-736. (PMID: 33475986); Circulation. 2020 Feb 25;141(8):652-654. (PMID: 31736331); Acta Cardiol. 2014 Apr;69(2):155-60. (PMID: 24783466); Heart Lung Circ. 2018 Feb;27(2):254-259. (PMID: 28545820); Heart Lung Circ. 2021 Sep;30(9):1356-1363. (PMID: 33745814); Pediatr Cardiol. 2010 Feb;31(2):175-80. (PMID: 19915891); Int J Cardiol. 2013 Sep 30;168(2):780-8. (PMID: 23154055); Heart. 2013 Oct;99(20):1530-4. (PMID: 23846614); J Cardiovasc Magn Reson. 2018 Dec 17;20(1):85. (PMID: 30558626); Circulation. 2012 Jan 17;125(2):250-9. (PMID: 22147905); Am J Cardiol. 2011 Aug 1;108(3):428-34. (PMID: 21600541); Heart Lung Circ. 2015 Aug;24(8):753-68. (PMID: 25911145); Front Cardiovasc Med. 2021 Dec 07;8:764273. (PMID: 34950712); Sports Med. 2021 Jul;51(7):1335-1351. (PMID: 33983613); Pediatr Cardiol. 2021 Jan;42(1):158-168. (PMID: 32975603); J Am Heart Assoc. 2020 Dec 15;9(24):e016850. (PMID: 33317366); Int J Cardiol. 2016 Sep 15;219:14-9. (PMID: 27257850); J Am Soc Echocardiogr. 2014 Jun;27(6):666-74. (PMID: 24637059); Am J Cardiol. 2016 May 15;117(10):1667-1671. (PMID: 27032711); J Am Coll Cardiol. 2012 Nov 13;60(20):2115-21. (PMID: 23083785); Eur Heart J. 2010 Dec;31(24):3073-83. (PMID: 20929979); Ann Thorac Surg. 2009 Dec;88(6):1961-9. (PMID: 19932269); Pediatr Cardiol. 2017 Jun;38(5):981-990. (PMID: 28500413); Pediatr Cardiol. 2018 Oct;39(7):1339-1345. (PMID: 29785512); BMJ. 2004 Jan 24;328(7433):189. (PMID: 14729656); Circulation. 2007 Sep 11;116(11 Suppl):I157-64. (PMID: 17846297); J Cardiol. 2018 Jan;71(1):88-92. (PMID: 28687271); Eur J Prev Cardiol. 2018 Mar;25(4):354-361. (PMID: 29313373); Cardiol Young. 2018 Mar;28(3):438-446. (PMID: 29237518); Eur J Prev Cardiol. 2019 Mar;26(5):492-501. (PMID: 30501371); Circulation. 1999 Mar 9;99(9):1173-82. (PMID: 10069785); J Am Coll Cardiol. 2008 Jul 8;52(2):99-107. (PMID: 18598887); Int J Cardiol. 2018 Nov 15;271:54-59. (PMID: 29861103); Circulation. 1997 Sep 2;96(5):1507-12. (PMID: 9315539); J Am Coll Cardiol. 2011 Jun 14;57(24):2437-43. (PMID: 21658565); Cardiol Young. 2009 Aug;19(4):340-5. (PMID: 19523267); Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H335-H344. (PMID: 30388023); Heart. 2018 Apr;104(8):680-684. (PMID: 28988207); Can J Cardiol. 2019 Dec;35(12):1815-1823. (PMID: 31473068); Am Heart J. 2013 Aug;166(2):365-372.e1. (PMID: 23895821); J Cardiovasc Med (Hagerstown). 2007 Oct;8(10):775-81. (PMID: 17885514); J Am Heart Assoc. 2020 Dec 15;9(24):e018345. (PMID: 33289459); J Cardiopulm Rehabil Prev. 2008 Jan-Feb;28(1):48-51. (PMID: 18277831); Cardiol Young. 2018 Nov;28(11):1299-1305. (PMID: 30149816); Circulation. 2019 Jul 1;:CIR0000000000000696. (PMID: 31256636); Eur J Prev Cardiol. 2021 Sep 20;28(11):1269-1278. (PMID: 34551076); Am Heart J. 2017 Jul;189:184-192. (PMID: 28625375); Circulation. 2014 Dec 2;130(23):2021-30. (PMID: 25446057); Open Heart. 2018 Jul 3;5(1):e000812. (PMID: 30057765); J Am Heart Assoc. 2019 May 7;8(9):e012008. (PMID: 31041880); Int J Cardiol. 2020 Nov 15;319:69-70. (PMID: 32598992); Cardiol Young. 2013 Dec;23(6):82 -30. (PMID: 24401254). Linking ISSN: 22962360. Subset: PubMed not MEDLINE; Date of Electronic Publication: 2022 Jan 06. ; Original Imprints: Publication: Lausanne : Frontiers Media SA, [2013]- <br />